Epiontis was founded in 2003 by Dr. Sven Olek and Dr. Ulrich Hoffmueller. The company is headquartered in the Science- and Technology Park Adlershof in the south of Berlin, Germany - a leading site for Biotechnology and Life Sciences in Berlin-Brandenburg. Epiontis offers worldwide services. Using a novel molecular diagnostics technology, Epiontis offers an immune cell monitoring service as well as customized development of epigenetic assays. Epiontis' epigenetic assay format allows the identification and quantification of any cell type with accuracy and technical ease. The main field of use is the monitoring of immune cells in research and clinical studies for autoimmune and infectious diseases or cancer. Here, they offer a portfolio of established assays for immune cells. Examples include diagnostic assays for regulatory T cells (Tregs) and tumor infiltrating lymphocytes, with many other epigenetic assays under development. In addition, they develop customized immunmonitoring essays that serve your needs.

AUM LifeTech, Inc. is an American private company located in Philadelphia, PA, that develops nucleic acids platform. It was founded in 2013 by Mahesh Chand and Veenu Aishwarya. Veenu Aishwarya has been the CEO since the inception date.\nThe company says this about itself: AUM LifeTech is a Philadelphia-based preclinical stage biotechnology company focused on the development of non-viral gene therapy using RNA-targeting therapeutics. The company is utilizing its self-delivering RNA targeting antisense oligonucleotide technology for drug discovery and development for unmet clinical needs with a focus on genetically-defined diseases. AUM LifeTech is also developing non-GMO, non-viral gene silencing products for sustainable and precision agriculture. AUM LifeTech strives to innovate at the genetic level for a better life.

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. It operates through the following business segments: Business to Business (BtoB), Business to Consumer (BtoC), and Biomedical. The BtoB segment offers functional materials such as Pharma GABA, Bone Pep, Lampep, HGP, and Pharma Biomix. The BtoC segment provides health food such as Tamagosamin; quasi-drugs such as Pneumo Ikumozai; and cosmetics such as Tamahada no Umitsu and Derma Q II Mild Peeling Gel. The Biomedical segment deals in life science information (LSI) business, which handles the research and development of antibody drugs using ALAgene technology. The company was founded on September 12, 1997 and is headquartered in Kyoto, Japan.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Celltech R&D Ltd., part of UCB SA, is a British company located in Slough. The firm engages in drug discovery and development. It was founded in 1980.

UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including University College Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.

Guangdong Haida Animal Veterinary Research Institute Co., Ltd., part of Guangzhou Haihao Investment Co Ltd, is a company headquartered in Guangzhou, China. The firm manufactures and distributes agricultural products; provides agricultural technology research services; provides veterinary services.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Suzhou GenePharma Co.,Ltd. engages in the manufacture of biotechnology products. Its products cover chemically-synthetic RNA monomer, custom siRNA oligo, chemically-modified RNA oligo, fluorescent dye for biological macromolecules marker; Biosynthesis siRNA, shRNA; DNAs encoding shRNA, plasmid vector encoding shRNA; RNAi service based on chemical synthesis, RNAi service based on vector regulation; siRNA related reagents and RNA-related product sales; common molecular biology reagent and laboratory supplies sales. The company was founded on August 27, 2007 and is headquartered in Shanghai, China.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Xinkaiyuan Jinhe Hebei Biotechnology Co., Ltd., established on 2017-12-08, Business scope includes biotechnology,medicine,medical instruments,computer software development,technical consulting,technology transfer,medical instruments(The operating permit),Laboratory equipment and consumables,Instrumentation(Does not include measuring instruments),Sports Equipment,Equipment,photographic equipment,office equipment,Computer hardware and software and auxiliary equipment,Sales of Home Appliances,Installation and Maintenance,Machinery and Equipment Leasing,computer system integration;food sales(The operating permit).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Sichuan Jinyu Medical Laboratory Co., Ltd., established on 2010-03-03, Business scope includes licensed projects:medical service;Inspection and testing service;Class III medical device business;road freight transport(Does not contain dangerous goods);Class III Medical Device Leasing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Sales of Class II Medical Devices;Class II Medical Device Leasing;Sales of Class I Medical Devices;Class I Medical Device Leasing;Medical Research and Experimental Development;Health Consulting Services(Does not include medical services);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Development of Human Gene Diagnosis and Therapy Technology;Domestic Freight Forwarding;total mass4.5Road freight transport of ordinary freight vehicles of 1 ton or less(Except network freight and dangerous goods);General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval);Labor service(Does not include labor dispatch);software development;Information Technology Consulting Services;Information system integration service.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shenzhen Longgang District People's Hospital (doing business as Longgang District People's Hospital of Shenzhen) is a Chinese private company located in Shenzhen. The firm operates general medical and surgical hospital.

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.